Holen Sie sich die Stockscreener-App
89.02
7.97%
6.57
Schlusskurs vom Vortag:
$82.45
Offen:
$83.13
24-Stunden-Volumen:
552.74K
Relative Volume:
0.96
Marktkapitalisierung:
$2.67B
Einnahmen:
$560.03M
Nettoeinkommen (Verlust:
$-150.66M
KGV:
-25.73
EPS:
-3.46
Netto-Cashflow:
$-87.43M
1W Leistung:
+20.72%
1M Leistung:
+17.63%
6M Leistung:
+0.09%
1J Leistung:
+0.83%
1-Tages-Spanne:
$82.55
$89.10
1-Wochen-Bereich:
$71.00
$89.10
52-Wochen-Spanne:
$55.92
$124.11
Irhythm Technologies Inc Stock (IRTC) Company Profile
Firmenname
Irhythm Technologies Inc
Sektor
Branche
Telefon
415-632-5700
Adresse
699 8TH STREET, San Francisco, CA
Vergleichen Sie IRTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
89.02 | 2.67B | 560.03M | -150.66M | -87.43M | -3.46 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-06-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-07 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-02-24 | Hochstufung | Needham | Hold → Buy |
| 2022-01-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-06-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-04-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Bestätigt | Needham | Hold |
| 2020-11-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Eingeleitet | Needham | Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-08-07 | Hochstufung | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-10 | Eingeleitet | William Blair | Outperform |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Perform |
| 2019-02-20 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Bestätigt | Canaccord Genuity | Buy |
| 2018-09-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-08-02 | Hochstufung | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Herabstufung | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Eingeleitet | Dougherty & Company | Neutral |
Alle ansehen
Irhythm Technologies Inc Aktie (IRTC) Neueste Nachrichten
20,173 Shares in iRhythm Technologies, Inc. (NASDAQ:IRTC) Bought by Dynamic Technology Lab Private Ltd - MarketBeat
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Sold by Westfield Capital Management Co. LP - MarketBeat
Eagle Asset Management Inc. Buys 31,193 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
iRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Champlain Investment Partners LLC Lowers Stock Position in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
Long Term Trading Analysis for (IRTC) - Stock Traders Daily
B. Metzler seel. Sohn & Co. Holding AG Takes Position in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $52.50 Million Stake in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
IRhythm Technologies To Participate In The Citi 2024 Global Healthcare Conference - Barchart
iRhythm Technologies to Present at Citi 2024 Global Healthcare Conference | IRTC Stock News - StockTitan
iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference - The Manila Times
IRTCiRhythm Technologies, Inc Latest Stock News & Market Updates - StockTitan
iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring - The Manila Times
iRhythm's New Studies Show 94.8% Device Compliance, 14% Better Comfort with Zio Monitor | IRTC Stock News - StockTitan
Short Interest in iRhythm Technologies, Inc. (NASDAQ:IRTC) Expands By 8.7% - MarketBeat
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Bought by State of New Jersey Common Pension Fund D - MarketBeat
iRhythm Technologies amends equity plan and code of ethics - Investing.com
iRhythm Technologies Updates Equity Incentive Plan - TipRanks
IRhythm Technologies : Amendments to Code of Ethics Form 8 K - Marketscreener.com
Frank Sands' Strategic Acquisition in iRhythm Technologies Inc - GuruFocus.com
(IRTC) Trading Report - Stock Traders Daily
Capital Research Global Investors Reduces Stake in iRhythm Techn - GuruFocus.com
Artisan Partners Limited Partnership Bolsters Stake in iRhythm T - GuruFocus.com
Abstract 4139306: Digital engagement with a patient smartphone app and text messaging is associated with increased compliance in patients undergoing long-term continuous ambulatory cardiac monitoring - AHA Journals
Abstract 4143857: Characterization of Arrhythmia Occurrence During Sleep and Activity in Patients Undergoing Long-Term Continuous Ambulatory ECG Monitoring - AHA Journals
Fiera Capital Corp Sells 11,553 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
Have Insiders Sold iRhythm Technologies Shares Recently? - Simply Wall St
New York State Common Retirement Fund Trims Stock Position in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
iRhythm technologies director buys $500,866 in common stock By Investing.com - Investing.com Canada
iRhythm technologies director buys $500,866 in common stock - Investing.com
IRhythm Technologies To Participate In The Wolfe Research 2024 Healthcare Conference - Barchart
iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference - WICZ
IRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference - Marketscreener.com
Director Abhijit Talwalkar Acquires 6,664 Shares of iRhythm Tech - GuruFocus.com
Quentin S. Blackford Sells 16,145 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) Stock - MarketBeat
Insider Buying: iRhythm Technologies, Inc. (NASDAQ:IRTC) Director Buys 6,664 Shares of Stock - MarketBeat
iRhythm technologies CEO Blackford sells $1.25 million in stock By Investing.com - Investing.com UK
iRhythm technologies CEO Blackford sells $1.25 million in stock - Investing.com
iRhythm Technologies (NASDAQ:IRTC) Trading Up 7.8%What's Next? - MarketBeat
iRhythm Technologies Inc (IRTC) Trading 4.41% Higher on Nov 4 - GuruFocus.com
Harbor Capital Advisors Inc. Has $5.94 Million Stock Holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
Emerging Opportunities in the Ecg Sensor Patch Market - openPR
Q1 EPS Forecast for iRhythm Technologies Lifted by Analyst - MarketBeat
Trend Tracker for (IRTC) - Stock Traders Daily
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Earnings call: iRhythm Reports Growth Amid FDA Remediation Efforts By Investing.com - Investing.com Australia
iRhythm Leaders Concealed Heart Monitor Deficiencies, Suit Says - Bloomberg Law
FDA clears iRhythm’s second 510(k) in response to warning letter - MedTech Dive
iRhythm Technologies Third Quarter 2024 Earnings: EPS Misses Expectations - Simply Wall St
Here’s Why iRhythm Technologies (IRTC) Slid in Q3 - Insider Monkey
iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported, And Analysts Assigned A US$101 Price Target - Yahoo Canada Finance
Finanzdaten der Irhythm Technologies Inc-Aktie (IRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):